| Coupled scRNA-Seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer Y Katzenelenbogen, F Sheban, A Yalin, I Yofe, D Svetlichnyy, DA Jaitin, ... Cell 182 (4), 872-885. e19, 2020 | 404 | 2020 |
| Cross-species single-cell analysis reveals divergence of the primate microglia program L Geirsdottir, E David, H Keren-Shaul, A Weiner, SC Bohlen, J Neuber, ... Cell 179 (7), 1609-1622. e16, 2019 | 395 | 2019 |
| LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma C Gur, SY Wang, F Sheban, M Zada, B Li, F Kharouf, H Peleg, S Aamar, ... Cell, 2022 | 105 | 2022 |
| Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma D Kirschenbaum, K Xie, F Ingelfinger, Y Katzenelenbogen, K Abadie, ... Cell, 2023 | 70 | 2023 |
| Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program L Geirsdottir, E David, H Keren-Shaul, A Weiner, SC Bohlen, J Neuber, ... Cell 181 (3), 746, 2020 | 49 | 2020 |
| The transcriptional and regulatory identity of erythropoietin producing cells BK Kragesteen, A Giladi, E David, S Halevi, L Geirsdóttir, OM Lempke, ... Nature Medicine, 1-10, 2023 | 47 | 2023 |
| Spatial and temporal mapping of breast cancer lung metastases identify TREM2 macrophages as regulators of the metastatic boundary I Yofe, T Shami, N Cohen, T Landsberger, F Sheban, L Stoler-Barak, ... Cancer Discovery, 2023 | 36 | 2023 |
| It Takes Two to Tango: The Role of Tumor-Associated Macrophages in T Cell-Directed Immune Checkpoint Blockade Therapy F Sheban Frontiers in Immunology 14, 2967, 2023 | 4 | 2023 |
| Antibodies for treating cancer I Amit, C Bornstein-ovits, A Yalin, A Moshe, O Barboy, A Weiner, ... US Patent App. 18/432,214, 2024 | | 2024 |
| Methods of treating cancer I Amit, A Weiner, Y Katzenelenbogen, A Yalin, F Sheban US Patent App. 17/876,641, 2022 | | 2022 |
Ido AmitProfessor of Immunology, Weizmann Institute of ScienceDirección de correo verificada de weizmann.ac.il